ArticleFrontiers in surgery2024
Localized abdominal wall metastasis of papillary renal cell carcinoma: a case report.
Article in Frontiers in surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Papillary renal cell carcinoma accounts for one tenth of all renal cell carcinomas. Compared to other renal cell carcinoma subtypes, it is more often localized at the time of diagnosis and rarely metastasizes to the skin. There are no previously reported cases of cutaneous papillary renal cell carcinoma localized to the abdominal wall which we present here. Case presentation: A 77 year-old female with multiple previous cancers, including a stage 1 left papillary renal cell carcinoma, treated with partial nephrectomy 32 months prior to presentation, was found to have a left upper abdominal wall mass on interval screening computed tomography. Fine needle aspiration was performed, obtaining limited tissue, followed by incisional biopsy. Histology and immunohistochemistry were consistent with renal cell carcinoma. She underwent operative excision of the abdominal wall mass with reconstruction using mesh and left posterior rectus fascial release. Histology and immunohistochemistry of the operative specimen reconfirmed the diagnosis of cutaneous metastasis of renal cell carcinoma. She was treated with adjuvant pembrolizumab and has no existing evidence of disease. Conclusions: Papillary renal cell carcinoma metastasized to the skin is uncommon, especially when localized to the abdominal wall without any other sites of metastases. Metastasis should be on the differential diagnosis when evaluating newly identified abdominal masses in patients with a history of papillary renal cell carcinoma. When localized, abdominal wall metastasis of papillary renal cell carcinoma can be effectively treated with resection and reconstruction, followed by systemic therapy when indicated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.